热门资讯> 正文
VivoSim推出400万美元的认股权证和两部分结构
2026-03-30 23:01
- VivoSim (VIVS) plans a best-efforts public offering of up to $4M in common stock or pre-funded warrants, plus warrants tied to up to $15M in shares.
- Each unit includes a share or pre-funded warrant and a warrant to buy 1.5 shares, priced at an assumed $1.69 per unit.
- Common warrants are immediately exercisable, expire in five years, and include anti-dilution price protection with a $0.01 floor.
- The offering includes two tranches: $3M initial and $1M second tranche subject to stock price and liquidity conditions.
- Pre-funded warrants are offered to investors to avoid exceeding 4.99% or 9.99% ownership limits.
- Total potential dilution includes millions of shares underlying warrants and pre-funded instruments.
More on Organovo Holdings
- Financial information for Organovo Holdings
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
